Market is very weak right now, looking for opportunities if we see a shift in funds from big tech to small cap opportunities. Most of these have some bullish divergence, also solid cash position for most as well.
$ADTX Thesis:
-$36M Market Cap
-Recent $11M funding
-Potential catalyst in additional news on acquisition of a bio-tech company that is commercializing COVID-19 antiviral oral therapy
$HEXO Thesis:
$513M Market Cap
-Raised $145M in August at $2.95/share
-Looking for opportunities for a cannabis sector rebound
$ORN Thesis:
$168M Market Cap
-Recent Contracts signed of $200M, $22M, $61M, $26M etc...
-Stumbled upon this one, like the technical set up and positive news
$XELA Thesis:
$280M Market Cap
-Positive recent news on $400M capital deployment and reduction of debt
$ADTX Thesis:
-$36M Market Cap
-Recent $11M funding
-Potential catalyst in additional news on acquisition of a bio-tech company that is commercializing COVID-19 antiviral oral therapy
$HEXO Thesis:
$513M Market Cap
-Raised $145M in August at $2.95/share
-Looking for opportunities for a cannabis sector rebound
$ORN Thesis:
$168M Market Cap
-Recent Contracts signed of $200M, $22M, $61M, $26M etc...
-Stumbled upon this one, like the technical set up and positive news
$XELA Thesis:
$280M Market Cap
-Positive recent news on $400M capital deployment and reduction of debt